Lexeo Therapeutics, Inc. ($LXEO)
Filing Information
| Accession Number | 0002024096-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 6, 2026 |
| Document Date | Feb 4, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
325,000
Total Value
$0.00
P&L
+inf% (+$1,836,250.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Feb 4, 2026 | Grant/Award | 65,000 | $0.00 | $0.00 | 128,476 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (right to buy) | Derivative | Feb 4, 2026 | Grant/Award | 260,000 | $0.00 | $0.00 | 260,000 | Direct | โ | View Details |